The restructuring of mobile imaging firm Maxum Health resulted in the Dallas-based company postinga net profit of $4.2 million for fiscal 1994 (end-December). Maxumsaid it restructured most of its debt and leasing arrangementsin 1994 and entered into a
The restructuring of mobile imaging firm Maxum Health resulted in the Dallas-based company postinga net profit of $4.2 million for fiscal 1994 (end-December). Maxumsaid it restructured most of its debt and leasing arrangementsin 1994 and entered into a long-term contract with hospital giantColumbia/HCA to run an outpatient imaging center. Maxum beganthe restructuring effort in 1993 (SCAN 3/24/93).
Maxum posted year-end revenues of $45.9 million, up slightlyfrom $45.1 million the year before. The company's net income of$4.2 million represented a major turnaround from the $6.8 millionnet loss recorded in 1993. Much of Maxum's improvement in profitabilitywas attributable to several extraordinary gains, including $3.3million related to extinguishment of debt and $5 million for thesale of its lithotripsy partnership interests. The firm's operatingloss for 1994 stood at $2.8 million, compared to a $6 millionoperating loss in 1993.
Maxum earlier this year partnered with Columbia/HCA to purchaseArlington Diagnostic and Imaging Center in Arlington, VA. Thecenter is jointly owned by the two companies, with Maxum responsiblefor staffing and management.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.